Sequential EGFR mutation and ALK rearrangement in adenocarcinoma lung, with rare metastasis to bilateral breast, ovary and endometrium

With the advent of targeted therapies there was a paradigm shift in the treatment of metastatic adenocarcinoma of lung. Immuno-histopathology and molecular subtyping in metastatic adenocarcinoma lung have enabled personalized treatment for each patient. Oncogenic driver mutations in non-small cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Anjali, V.R., Pandey, Rambha, Srivastava, Astha, Rajeshwari, Madhu, Pandey, Durgatosh, Sharma, M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838794/
https://www.ncbi.nlm.nih.gov/pubmed/31720204
http://dx.doi.org/10.1016/j.rmcr.2019.100954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838794/
https://www.ncbi.nlm.nih.gov/pubmed/31720204
http://dx.doi.org/10.1016/j.rmcr.2019.100954

Ejemplares similares